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Does Respiratory Infection
Due to Chlamydia
pneumoniae Still Exist?
To the Editor—Since the late 1980s,
Chlamydia pneumoniae has been con-
sidered an agent of community-acquired
pneumonia and of other respiratory
tract infections affecting all ages [1]. The
common occurrence of C. pneumoniae
infection is suggested by the high sero-
prevalence ($70%) observed in adults
[2]. However, in recent studies [3–5],
the prevalence of respiratory infections
due to C. pneumoniae was reported to be
much lower (,1.5%) than previously
(6%–22%) [6]. This apparent decrease
in the prevalence of C. pneumoniae in-
fection could be due to changes in
the epidemiological characteristics of
C. pneumoniae over time, to increased
specificity of new diagnostic methods, or
to the difficulty for clinicians to target
the infected population.
In our university hospital, we routinely
use a multiplex real-time polymerase
chain reaction (PCR) for the detection of
C. pneumoniae and Mycoplasma pneu-
moniae DNA [7]. From October 2001
through June 2010, a total of 2244 re-
spiratory specimens retrieved from 1583
patients were sent to the laboratory for
C. pneumoniae and/or M. pneumoniae
PCR, including 884 bronchoalveolar la-
vage samples, 843 nasopharyngeal swab
samples, 354 bronchial aspirate samples,
111 sputum samples, and 52 other sam-
ples. Only 4 samples (0.2%) taken from
2 patients were positive for C. pneumo-
niae, whereas 76 samples (3.4%) were
positive forM. pneumoniae in 65 patients.
In both cases, the diagnosis of C. pneu-
moniae infection was not suspected by the
clinician and the test was performed
thanks to the multiplex format of our
molecular test.
The first patient with C. pneumoniae
infection was a 48-year-old man re-
ceiving immunosuppressive therapy for
inflammatory bowel disease. He pre-
sented with a chronic cough initially
suspected to be asthma and a febrile
episode. PCRs performed on sputum
samples obtained on day 0 and day 4 had
highly positive results, with 2,285,300
copies/mL (Ct 5 24.6) and 2,389,200
copies/mL (Ct 5 25). The amount of
DNA decreased to 465 copies/mL (Ct 5
37.2) in 17 days. In the presence of
a persistent dry cough despite the falling
bacterial load, clarithromycin 500 mg
per day was administered for 2 weeks.
Clinical evolution was favorable under
antimicrobial therapy with rapid de-
crease of cough. Follow-up PCRs at days
34 and 48 had negative results.
The second patient with C. pneumo-
niae infection was a healthy 13-year-old
girl presenting with a third episode of
pneumonia over a 5-month period. PCR
performed on a nasopharyngeal swab
sample yielded positive results, with 153
copies/mL (Ct 5 36.5). The patient’s
condition improved with clarithromycin
therapy.
This study confirms that C. pneumo-
niae is rarely detected, at least in our
setting, because only 2 of 1583 patients
were identified with C. pneumoniae in-
fection during a 10-year period. This
may reflect a low prevalence of the dis-
ease and/or suggests that clinicians do
not target the right population. The
second hypothesis is supported by the
fact that both cases were not suspected
by the physician in charge and the eti-
ological diagnosis was made thanks to
the duplex approach of our molecular
test. Because C. pneumoniae infection
may be associated with persistent cough
in adults [8, 9], it should be included in
the differential diagnosis of chronic
cough and asthma.
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